‘Gated’ CAR T-Cells Are Effective Against AML—With Less Toxicity
January 21, 2025
The novel approach marks a significant step forward in developing CAR T-cell therapy for acute myeloid leukemia.
Moghimi Laboratory News
Children’s Hospital Los Angeles Awarded $6 Million from CIRM to Advance CAR T-Cell Therapies in Recurring Solid Tumors in Children
February 29, 2024
CHLA Researchers receive CIRM award to develop regenerative therapy for recurring solid tumors in children.
5 Things to Know About Advances in Cancer Research
July 3, 2023
Dramatic advances in cancer research and treatment over the past two decades have made it possible for more children to survive a cancer diagnosis.
New cGMP Facility Aims to Accelerate Cell Therapy for Pediatric Cancer
May 12, 2023
Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.
Study Leads to Orphan Drug Status for Acute Myeloid Leukemia
January 10, 2023
Research at Children’s Hospital Los Angeles enables a novel compound to achieve a key designation from the Food and Drug Administration.
Meet Some of our Research Trainees
December 17, 2021
Stephanie Yi-Tsi Chen, MD Stephanie is a research resident and fellow investigating immunotherapy resistance in neuroblastoma. Stephanie’s dream is to become a pediatric surgeon at an academic
Cell Therapy Program Expands
February 15, 2021
With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.
Creating a Safe CAR T-Cell Therapy to Fight Solid Tumors in Children
January 22, 2021
Scientists at Children’s Hospital Los Angeles develop newer CAR T therapy that promises to be more effective and less toxic for children with neuroblastoma.